Disclosures: The authors report no relevant financial disclosures.
February 26, 2021
4 min read
Save

Prediabetes diagnosis poor predictor of disease progression for older adults

Disclosures: The authors report no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Older adults with an HbA1c in the prediabetes range were far more likely to revert to normoglycemia or die during 5-year follow-up than to progress to overt type 2 diabetes, according to a community-based study.

The findings suggest that prediabetes may not be a “robust diagnostic entity in older age,” the researchers wrote in a study published in JAMA Internal Medicine.

About 60% of older adults with prediabetes either returned to normoglycemia or died during a 5-year follow-up.

“Prediabetes is defined by elevated blood glucose levels below the threshold for diabetes diagnosis,” Mary R. Rooney, PhD, MPH, a postdoctoral fellow at Johns Hopkins University Bloomberg School of Public Health, told Healio. “Physicians screen for prediabetes to identify patients at high risk for diabetes. While we knew that a mildly elevated glucose or HbA1c is a common finding in older patients, whether these patients are more likely to progress to diabetes has been an unresolved question.”

Disease incidence low

Rooney and colleagues analyzed data from 3,412 older adults without diabetes at baseline participating in the Atherosclerosis Risk in Communities (ARIC) study (baseline, 2011-2013; mean age, 76 years; 60% women; 17% Black).

Participants were contacted semiannually through December 2017, and attended a follow-up visit between 2016 and 2017; median follow-up was 5 years.

Researchers defined prediabetes as an HbA1c between 5.7% and 6.4%, an impaired fasting glucose level between 100 mg/dL and 125 mg/dL, or both.

Primary outcome was incident total diabetes, defined as a physician diagnosis, glucose-lowering medication use, an HbA1c of at least 6.5% or a fasting glucose of at least 126 mg/dL.

Mary R. Rooney

At baseline, 1,490 participants (44%) had HbA1c levels ranging from 5.7% to 6.4%, 1,996 (59%) had IFG, 2,482 (73%) met the HbA1c or IFG criteria for prediabetes, and 1,004 (29%) met both the HbA1c and IFG criteria.

Within the cohort, 2,497 participants attended the follow-up visit or died. During follow-up, researchers observed 156 incident total diabetes cases (118 physician diagnosed) and 434 deaths.

Among participants with baseline HbA1c levels of 5.7% to 6.4%, 97 (9%) progressed to type 2 diabetes, 148 (13%) regressed to normoglycemia and 207 (19%) died. Among those with IFG at baseline, 112 (8%) progressed to type 2 diabetes, 647 (44%) regressed to normoglycemia and 236 (16%) died.

Among participants with a baseline HbA1c level that was less than 5.7%, 239 (17%) progressed to an HbA1c in the prediabetes range and 41 (3%) developed type 2 diabetes. Of those with baseline fasting glucose levels less than 100 mg/dL, 80 (8%) progressed to IFG and 26 (3%) developed type 2 diabetes.

“Indeed, in older adults with prediabetes, regression to normoglycemia or death was more common than progression to diabetes during the study period,” the researchers wrote.

An ‘optimal’ prediabetes definition

Depending on the definition, the prevalence of prediabetes in the study ranged from 29% to 73%, the researchers noted. In secondary analyses, prediabetes prevalence based on international criteria was lower, at 15%, based on the international expert committee criterion of an HbA1c level range of 6% to 6.4%, and 23% based on WHO criteria of fasting glucose levels of 110 mg/dL to 126 mg/dL.

“The various definitions and wide range in prevalence estimates pose challenges for understanding the burden of prediabetes in the population and its clinical and public health relevance,” the researchers wrote. “The different definitions of prediabetes also have differing performance for assessing future diabetes.”

The researchers found that specificity was highest for prediabetes based on a confirmatory definition — both HbA1c levels of 5.7% to 6.4% and IFG — but specificity was lowest when based on either HbA1c levels of 5.7% to 6.4% or IFG.

“Conversely, sensitivity for the association with total or diagnosed diabetes was highest for prediabetes based on HbA1c levels of 5.7% to 6.4% or IFG and lowest for the confirmatory definition,” the researchers wrote. “The more stringent international definitions for prediabetes had higher specificity for the association with both diabetes outcomes, but sensitivity was lower. These differences in diagnostic performance have implications for screening strategies for diabetes.”

Rooney said that a prediabetes diagnosis for an older adult still presents an opportunity for lifestyle changes.

“However, in older adults, as we found, an HbA1c in the prediabetes range may not be a robust predictor of progression to diabetes,” Rooney said. “This common lab finding can still present an opportunity to encourage lifestyle improvements, including exercise and diet, when feasible and safe. This approach has broad benefits for patients.”

For more information:

Mary R. Rooney, PhD, MPH, can be reached at mroone12@jhu.edu.